X

Biotechnology

AbbVie (ABBV) Q4 2022 Earnings: Key financials and quarterly highlights

AbbVie (NYSE: ABBV) reported fourth quarter 2022 earnings results today. Worldwide net revenues increased 1.6% year-over-year to $15.1 billion. Net…

CVS Earnings: CVS Health Q4 2022 profit, revenue increase

CVS Health Corporation (NYSE: CVS) on Wednesday announced financial results for the fourth quarter of 2022, reporting a modest increase…

Illumina Inc (ILMN) Q4 2022 Earnings Call Transcript

Illumina Inc (NASDAQ:ILMN) Q4 2022 Earnings Call dated Feb. 07, 2023. Corporate Participants: Salli Schwartz -- Vice-President of Investor Relations Francis deSouza -- President…

Vertex Pharmaceuticals Incorporated (VRTX) Q4 2022 Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2022 earnings call dated Feb. 07, 2023 Corporate Participants: Susie Lisa -- Senior Vice President, Investor…

Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31%

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged…

Merck (MRK) Earnings: 4Q22 Key Numbers

Merck (NYSE: MRK) reported fourth quarter 2022 earnings results today. Sales increased 2% year-over-year to $13.8 billion. GAAP net income…

BMY Earnings: Everything you need to know about Bristol Myers’ Q4 results

Bristol Myers Squibb (NYSE: BMY) on Thursday announced results for the fourth quarter of 2022, reporting lower earnings and revenues.…

AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues

Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm's earnings…

Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results

Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today. Net sales declined 12% year-over-year to $10.1 billion. Net…

Cadrenal Therapeutics downsizes IPO, looks to raise $7 million

There has been an increase in the number of pharma companies taking the IPO route to enhance their research and…

WBA Stock: Should you invest in Walgreens Boots Alliance ahead of earnings?

Walgreens Boots Alliance, Inc.  (NASDAQ: WBA) has been a key contributor to the COVID-19 vaccination campaign, supported by its extensive…

Cancer drug maker Felicitex prepares for IPO. Here’s all you need to know

Fewer companies filed for initial public offering this year, compared to 2021 when the market witnessed a record number of…

Novavax Inc (NVAX) Q3 2022 Earnings Call Transcript

Novavax Inc (NASDAQ:NVAX) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Silvia Taylor -- Executive Vice President, Chief Communications Officer…

Consider these factors before investing in Eli Lilly and Company (LLY)

The stock performance of Eli Lilly and Company (NYSE: LLY) has been exceptionally good this year, with the pharma giant…

Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results

Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The…

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2022 Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2022 earnings call dated Oct. 27, 2022 Corporate Participants: Susie Lisa -- Senior Vice President, Investor…

BioMarin Pharmaceutical Inc. (BMRN) Q3 2022 Earnings Call Transcript

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Traci McCarty -- Vice President of Investor…

ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while…

Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings

Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when…

BIIB Stock: Is Biogen an investment worth trying now?

Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced…

Bristol Myers Squibb (BMY) Earnings: 3Q22 Key Numbers

Bristol Myers Squibb (NYSE: BMY) reported revenues of $11.2 billion for the third quarter of 2022, down 3% from the…